Additionally, it has been reported that CD83 expression is reduced in the airways of COPD patients and is associated with the expression level of TGF-β, which may inhibit the maturation of DCs as well as CD83 expression [18, 19]. This evidence concerns the gene CD83 and chronic obstructive pulmonary disease.